Ultraconserved regions (UCRs) are non-protein coding gene sequences with strict conserved across among different species. Emerging evidence demonstrates that UCRs encoding noncoding RNAs (ncRNAs) serve as regulators of gene expression. In recent decades, increasing evidence implicates the involvement of UCRs in carcinogenesis. Previous studies showed RNA expression of uc.206 was increased in colorectal cancer. Until now, the role of uc.206 in cervical cancers remains undefined. This study revealed that uc.206 is significantly up-regulated in cervical cancer (CC) tissue and negatively correlates with the expression of the pro-apoptotic gene P53 in RNA level. We show that uc.206 specifically targets the 3' untranslated region (3'UTR) of P53 and regulates its expression. Inhibition of uc.206 effectively delays cervical cells proliferation and promotes apoptosis, accompanied by increased expression of P53 protein. Thus, these findings suggested that uc.206 acts as a novel oncogene by targeting the P53 gene and promoting CC cell growth, which might be beneficial for cervical cancer therapy.
Cervical cancer is the second most common cause of female specific cancer after breast cancer and the fourth leading cause of cancer mortality in women worldwide (1) . Approximately 80% of cervical cancers occur in developing countries (2) .
Because detection of precursors by cytological examination and their eradication by laser vaporization or cone biopsy is the most effective method of cervical cancer prevention, the carcinoma is very treatable, and in many cases, curable. However, once this cancer grows again and spreads to the distant lymph nodes, the outlook is fatal in advanced carcinoma (3) . Therefore, it is essential to identify proliferation-associated molecules and to better understand the mechanisms behind the growth of cervical carcinoma.
Ultraconserved regions (UCRs) are noncoding gene sequences with strict conserved across among mice, rats, and humans. It belongs to part of non-protein-coding DNA and regulates expression and translation of mRNAs. Emerging evidence demonstrates that UCRs can encode non-protein-coding RNAs (ncRNAs) serve as modulators of gene expression (4, 5).
Previous genome expression profiling studies showed that transcribed ultraconserved RNAs (T-UCRs) exhibit different profiles in human carcinomas (6, 7) . Moreover, some T-UCRs serve as oncogenes or tumor suppressor genes in development of tumor. For example, the transcribed ultraconserved element 73 (uc.73) modulates cell proliferation in colorectal cancer cell lines (6) . However, the regulation of most T-UCRs and their precise mechanisms of action are not known in cervical carcinoma.
Uc.206 is one of T-UCRs. Calin GA, et al. studies indicated that RNA expression of uc.206 was up-regulated in colorectal cancer (6) . However, little is known about the expression level and biological role of uc.206 in cervical carcinoma.
In the presented study, the differential expression of uc.206 in human CC samples was identified using quantitative polymerase chain reaction (qPCR), and the function of uc.206 in proliferation and apoptosis of cervical cancer cells was investigated. In addition, to understand the growth mechanism of cervical cancer, the target gene of uc.206 was further investigated. To the best of our knowledge, this is the first study to investigate the expression and mechanism of uc.206 in cervical carcinoma proliferation. This study presents a novel target for further therapeutic studies of cervical cancer. 48 h before further experiments. The transfected cells were incubated at 37°C with 5% CO 2. The uc.206 and P53 RNA level in the transfected cervical cancer cells were identified by qRT-PCR.
Dual luciferase reporter assay. The full length 3'-UTR of P53 was amplified by PCR from genomic DNA and cloned into the EcoRI and XhaI sites of pGL3-BS vector (Promega, WI, USA). The primers for P53 3'-UTR were as follows: 5'-CATTCTCCACTTCTTGTTCC -3' and 5'-AGATGT-GCTTGCAGAATGTA -3'. The mutant construct of P53 3'UTR was generated using a Quick Change mutagenesis kit (Stratagene, Heidelberg, Germany). Co-transfection of reporter vectors and uc.206 mimics or negative control was performed using Lipofectamine 2000 (Invitrogen, San Diego, USA). After 48 h, dual luciferase activity was measured using a dual luciferase reporter assay system according to the manufacturer's protocol (Promega, WI, USA).
CCK8 assay. Cells (5 x 10 4 cells/ml) were transfected with uc.206 or the control vector for 48 h. Then each well was added with 10μl CCK-8 solution, and was incubated for 3h at 37 °C with 5% CO 2 . The absorbance was measured at 450 nm using a microplate reader (Promega, WI, USA).
Cell apoptosis assays. Cells were seeded in 6-well plates and transiently transfected with uc.206 and the control vector. After 48 hours the cells were washed with cold PBS twice and subsequently treated with 5μl of Annexin V and 10μl of propidium iodide (PI) using Alexa Fluor 488 annexin V/Dead Cell Apoptosis Kit (Invitrogen) to determine the cell apoptosis according to the protocol and then analysed by a flow cytometer (FACScalibur, NY, USA).
Western blot analysis. Proteins were extracted by Cell lysis for western kit (Beyotime, Jiangsu, China) according to the instructions. Protein concentration was quantified using Enhanced BCA protein assay kit (Beyotime, Jiangsu, China). For western blot analysis, equal amounts of total protein were boiled, and separated by SDS-PAGE. After electrophoresis, protein was blotted onto a PVDF membrane and blocked for 2 h at room temperature. Membranes were incubated with anti-P53 antibody (Cell Signaling Technologies, Boston, MA) at 1:1000 dilutions for overnight at 4 °C. P53 protein level was detected by horseradish peroxidase (HRP) conjugated mouse and rabbit secondary antibody (Beyotime, Jiangsu, China) for 2 h at room temperature. Protein bands were detected on FluorChem FC2 Imaging System (Alpha Innotech, San Leandro, CA).
Statistical analysis. Statistical analyses were performed using SPSS 16.0 software package (SPSS, Chicago, USA). All graphs were created using GraphPad Prism 5 software (GraphPad Software, La Jolla, CA, USA). All data from three independent experiments were expressed as mean ± SD. Differences were assessed by two-tailed Student's t test. The relationship between P53 and uc.206 expressions was tested with two-tailed Pearson's correlation. P < 0.05 was considered statistically significant. Figure 1A ). We also found that expression of uc.206 was much more in two cervical cancer cell lines than that of human cervical tissue cell (* p < 0.05, Figure 1B) . Collectively, the above findings suggest that excess of uc.206 expression may play an important role in tumorigenesis of cervical carcinoma. Figure 2A and 2B. The Hela cell line exhibited higher transfection efficiency than C33A cells; therefore, all of our experiments in this study were conducted in the Hela cell line. To detect the effect of uc.206 on proliferation of Hela cells, we performed CCK8 assays on the transfected Hela cells. Our data showed that over-expression of uc.206 led to a statistically significant increase in Hela cell proliferation compared to the negative control cells (p < 0.05, Figure 2C ). Conversely, the proliferation rate of the Hela cells treated with the uc.206 inhibitor was decreased when compared to control cells (p < 0.05, Figure 2D) .
Results

Expression
Next, we analyzed apoptosis in the transfected Hela cells via flow cytometry. As shown in Figure 3 Uc.206 was negatively correlated with P53 in the CC tissue. To assess the correlation of the uc.206 and P53 in cervical carcinoma, we detected the RNA levels of uc.206 and P53 in cervical carcinoma and adjacent normal cervical tissues by using qRT-PCR. As shown in Figure 6 , when the P53 mRNA levels were plotted against uc.206 expression, a significant inverse correlation was obtained by two-tailed Pearson's correlation analysis (r = −0.625; p < 0.05).
Knock down P53 in Hela cells promotes cell proliferation and inhibits cell apoptosis. To confirm the effects of P53 on the proliferation and apoptosis of Hela cell, P53 expression was knocked down by a P53 shRNA (sh-P53). The mRNA and protein expression of P53 was significantly down-regulated in Hela cell after P53 shRNA treatment ( Figure 7A) . Consistently, the knockdown of P53 strongly promotes cell proliferation and inhibits cell apoptosis in Hela cells, which resembled the over-expression effects of uc.206 ( Figure 7B, 7C) . These data suggest that knockdown of P53 promotes cell proliferation and inhibits cell apoptosis in CC cell and P53 is an effective target gene of uc. sequences with strict conserved across among mice, rats, and humans. It belongs to part of non-protein-coding DNA and regulates expression and translation of mRNAs. By regulating protein production post-transcriptionally, many UCRs act as oncogenes or tumor suppressor genes (6, (9) (10) (11) (12) . However, the regulation of uc.206 and its precise mechanisms of action in cervical cancers are not known.
P53, a tumor suppressor, inhibited cell proliferation by arresting cell cycle and inducing apoptosis in response to cellular stress [13, 14] . Disruption of P53 levels could promote tumor progression and inhibit apoptosis, but elevate the DNA damage [13, 15] . Previous report suggested that ncRNA could regulate P53 protein production post-transcriptionally. For example, anta-miR-150 treated tumor tissue, the expression of P53 is increased, and indicated P53 is the potential downstream target of miR-150 but the direct evidences were not provided [16] . By using luciferase reporter system, we verified miR-150 directly target P53 transcript at its 3'UTR and inhibit its translation [17] . overexpression of MEG3(a non-coding RNA) significantly stabilized p53 expression which leads to an increased level of P53 protein. Therefore, it is likely that MEG3 activates P53 through inhibition of P53 ubiquitination and blockage of P53 degradation [18] . Y zhou et al. have found that MDM2 expression was repressed by MEG3, suggesting that down-regulation in MDM2 protein levels contributes to P53 activation by MEG3 [19] .
In this study, we screened for 5 UCRs in 40 pair of CC patients and found that the RNA levels of uc.206 were significantly upregulated in CC tissues. We also found that the upregulation of uc.206 had negative correlation with mRNA levels of P53. By using dual luciferase reporter system, we found that P53 is directly targeted by uc.206. Over-expression of uc.206 promoted cell proliferation and inhibition of uc.206 suppressed cell proliferation and promoted apoptosis in Hela and C33A cells. Knockdown of P53 promotes cell proliferation and inhibits cell apoptosis in CC cell and overexpression of P53 in uc. 206 overexpression of Hela cells remarkably inhibited cell proliferation and promoted cell apoptosis.
In summary, these data illustrate the possible role of uc.206 and P53 expression in the pathogenesis of CC, uc.206 may be an important oncogene in cervical carcinoma, and uc.206 might be helpful in clinical diagnosis and therapy for preventing cervical cancer.
